Vedolizumab for Pouchitis

  • Intravenous Therapy
  • Limited to 200 patients
  • 1 Location

Vedolizumab is an intraveneous medication for ulcerative colitis who have had bowel surgery involving a proctocolectomy and ileal pouch anal anastomosis.

Eligibility Checklist

You may be eligible to participate if you meet the following criteria:

  • Ages 18 and older
  • Male or Female
See if you're eligible ›

How You Can Participate

This study is currently accepting candidates. You would receive medical care from Dr. Brian Bressler at GI Research Institute. Answer a few questions to see if you can participate ›

Frequently Asked Questions

How much does it cost?
The treatment and doctor visits are free.
Are traveling expenses covered?
Travel expenses will generally be covered.
I have more questions, who do I ask?
Contact us 1-800-794-6031 or


Here's a timeline of what you can expect:

Fill out quiz

Step 1: Online Pre-screener

Find out if you are a match by answering a few online questions.
Stay Informed ›


Step 2: Phone Call with Care Coordinator

Speak with our Care Team specialist to confirm your candidacy.

Baseline appointment

Step 3: Screening Appointment

If you are eligible to continue, you will be given an appointment date and time to come to the clinic for a screening visit.